Stockscreener 앱 받기
12.35
0.90%
0.11
시간 외 거래:
12.31
-0.04
-0.32%
전일 마감가:
$12.24
열려 있는:
$12.35
하루 거래량:
7,956
Relative Volume:
0.29
시가총액:
$107.92M
수익:
-
순이익/손실:
$-61.23M
주가수익비율:
-0.9135
EPS:
-13.5194
순현금흐름:
$22.49M
1주 성능:
-12.60%
1개월 성능:
+36.01%
6개월 성능:
-25.47%
1년 성능:
-7.84%
1일 변동 폭
$12.20
$12.45
1주일 범위
$11.64
$14.11
52주 변동 폭
$7.75
$19.93
Assembly Biosciences Inc Stock (ASMB) Company Profile
명칭
Assembly Biosciences Inc
전화
(833) 409-4583
주소
TWO TOWER PLACE, SOUTH SAN FRANCISCO
ASMB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
12.35 | 107.92M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.37 | 128.45B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.63 | 65.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
560.90 | 40.09B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.19 | 35.67B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
233.25 | 27.44B | 3.81B | -644.79M | -669.77M | -6.24 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-25 | 개시 | Guggenheim | Buy |
| 2024-09-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-09-13 | 개시 | H.C. Wainwright | Neutral |
| 2021-09-02 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-10-19 | 개시 | Truist | Buy |
| 2019-10-16 | 개시 | Mizuho | Buy |
| 2018-11-19 | 개시 | Leerink Partners | Outperform |
| 2018-10-08 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | 개시 | Robert W. Baird | Outperform |
| 2018-04-13 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | 개시 | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | 개시 | Jefferies | Buy |
| 2017-05-30 | 개시 | Chardan Capital Markets | Buy |
모두보기
Assembly Biosciences Inc 주식(ASMB)의 최신 뉴스
Assembly Biosciences First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Assembly Biosciences: Q1 Earnings Snapshot - New Haven Register
Assembly Biosciences Reports Q1 2025 Earnings - TipRanks
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Assembly Biosciences Inc (ASMB) Q1 2025 Earnings: EPS of -$1.17 Beats Estimate, Revenue of $9.4M Exceeds Forecast - GuruFocus
Assembly Biosciences Updates on Clinical Progress and Financials, Anticipates Key Data in 2025 - Nasdaq
Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates - The Manila Times
Assembly Biosciences (ASMB) Highlights Promising Preclinical Data at EASL Congress | ASMB Stock News - GuruFocus
New Preclinical Data for Assembly Biosciences' Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress 2025 - The Manila Times
Ribbon Bio Launches MiroSynth™ DNA Molecules to Unlock a New Era of Complex Synthetic DNA - Yahoo Finance
Raymond James Financial Inc. Invests $973,000 in Invesco 0-5 Yr US TIPS ETF (BATS:PBTP) - The AM Reporter
Assembly Biosciences (ASMB) Soars 24.0%: Is Further Upside Left in the Stock? - NewsBreak: Local News & Alerts
Learn to Evaluate (ASMB) using the Charts - news.stocktradersdaily.com
JPMorgan Chase & Co. Acquires 7,918 Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB) - Defense World
Assembly Biosciences Insiders Added US$679.4k Of Stock To Their Holdings - simplywall.st
Assembly Biosciences (NASDAQ:ASMB) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Renaissance Technologies LLC Boosts Stock Holdings in Assembly Biosciences, Inc. (NASDAQ:ASMB) - Defense World
Long Term Trading Analysis for (ASMB) - news.stocktradersdaily.com
Assembly Biosciences director sells $7,455 in stock - Investing.com Australia
Assembly Biosciences director sells $7,455 in stock By Investing.com - Investing.com South Africa
Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight - PR Newswire UK
Assembly Biosciences Presents New Data Highlighting Long-Acting - GuruFocus
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress - The Manila Times
Down -22.6% in 4 Weeks, Here's Why Assembly Biosciences (ASMB) Looks Ripe for a Turnaround - Yahoo Finance
ASMB stock touches 52-week low at $8.21 amid market challenges - Investing.com
ASMB stock touches 52-week low at $8.21 amid market challenges By Investing.com - Investing.com South Africa
Mastercard Is Taking On the World and Winning - The Globe and Mail
Assembly Biosciences, Inc. (NASDAQ:ASMB) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough - simplywall.st
(ASMB) Investment Report - news.stocktradersdaily.com
Consumer Internet Stocks Q4 Teardown: Remitly (NASDAQ:RELY) Vs The Rest - The Globe and Mail
Assembly Biosciences CEO sells shares worth $3,496 By Investing.com - Investing.com Canada
Assembly Biosciences officer sells $1,772 in stock By Investing.com - Investing.com South Africa
Assembly Biosciences CEO sells shares worth $3,496 - Investing.com
Assembly Biosciences officer sells shares for $1,940 - Investing.com India
Assembly Biosciences officer sells $1,772 in stock - Investing.com India
Five9 (FIVN): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail
ASMB stock touches 52-week low at $10.1 amid market challenges - Investing.com
Q4 Earnings Outperformers: Fastenal (NASDAQ:FAST) And The Rest Of The Maintenance and Repair Distributors Stocks - The Globe and Mail
Assembly Biosciences (ASMB) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Research Analysts Offer Predictions for ASMB Q1 Earnings - Defense World
Guggenheim Initiates Coverage of Assembly Biosciences (ASMB) with Buy Recommendation - MSN
Research Analysts Issue Forecasts for ASMB FY2029 Earnings - Defense World
Assembly Biosciences (NASDAQ:ASMB) Now Covered by Guggenheim - Defense World
Assembly Biosciences Reports 2024 Financial Results and Progress - TipRanks
This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Assembly Biosciences Inc (ASMB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.10%
자본화:
|
볼륨(24시간):